These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 31352655)

  • 1. Antiplatelet Therapy in Cerebral Small Vessel Disease.
    Bouasquevisque DS; Benavente OR; Shoamanesh A
    Curr Neurol Neurosci Rep; 2019 Jul; 19(9):61. PubMed ID: 31352655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.
    Al-Shahi Salman R; Minks DP; Mitra D; Rodrigues MA; Bhatnagar P; du Plessis JC; Joshi Y; Dennis MS; Murray GD; Newby DE; Sandercock PAG; Sprigg N; Stephen J; Sudlow CLM; Werring DJ; Whiteley WN; Wardlaw JM; White PM;
    Lancet Neurol; 2019 Jul; 18(7):643-652. PubMed ID: 31129065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of antiplatelet therapy in secondary prevention following lacunar stroke: pooled analysis of randomized trials.
    Kwok CS; Shoamanesh A; Copley HC; Myint PK; Loke YK; Benavente OR
    Stroke; 2015 Apr; 46(4):1014-23. PubMed ID: 25721018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet regimens in the long-term secondary prevention of transient ischaemic attack and ischaemic stroke: an updated network meta-analysis.
    Niu PP; Guo ZN; Jin H; Xing YQ; Yang Y
    BMJ Open; 2016 Mar; 6(3):e009013. PubMed ID: 26988347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials.
    Kheiri B; Osman M; Abdalla A; Haykal T; Swaid B; Ahmed S; Chahine A; Hassan M; Bachuwa G; Al Qasmi M; Bhatt DL
    J Thromb Thrombolysis; 2019 Feb; 47(2):233-247. PubMed ID: 30511260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.
    Lee M; Saver JL; Hong KS; Rao NM; Wu YL; Ovbiagele B
    Ann Intern Med; 2013 Oct; 159(7):463-70. PubMed ID: 24081287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.
    Davis KA; Miyares MA; Dietrich E
    Am J Health Syst Pharm; 2015 Oct; 72(19):1623-9. PubMed ID: 26386103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial.
    Toyoda K; Uchiyama S; Hoshino H; Kimura K; Origasa H; Naritomi H; Minematsu K; Yamaguchi T;
    Int J Stroke; 2015 Feb; 10(2):253-8. PubMed ID: 25487817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
    Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
    Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbleeds in the Secondary Prevention of Small Subcortical Strokes Trial: Stroke, mortality, and treatment interactions.
    Shoamanesh A; Pearce LA; Bazan C; Catanese L; McClure LA; Sharma M; Marti-Fabregas J; Anderson DC; Kase CS; Hart RG; Benavente OR;
    Ann Neurol; 2017 Aug; 82(2):196-207. PubMed ID: 28681535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy as a risk factor for microbleeds in intracerebral hemorrhage patients: analysis using specific antiplatelet agents.
    Naka H; Nomura E; Kitamura J; Imamura E; Wakabayashi S; Matsumoto M
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):834-40. PubMed ID: 22784819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on Dual Antiplatelet Therapy for Secondary Stroke Prevention.
    Stringberg A; Camden R; Qualls K; Naqvi SH
    Mo Med; 2019; 116(4):303-307. PubMed ID: 31527979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin plus clopidogrel as secondary prevention after stroke or transient ischemic attack: a systematic review and meta-analysis.
    Zhang Q; Wang C; Zheng M; Li Y; Li J; Zhang L; Shang X; Yan C
    Cerebrovasc Dis; 2015; 39(1):13-22. PubMed ID: 25547900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-stroke treatment with K-134, a phosphodiesterase 3 inhibitor, improves stroke outcomes in the stroke-prone spontaneously hypertensive rat model-A comparative evaluation of antiplatelet drugs.
    Yoshida H; Itoh S; Ferdousi F; Isoda H
    J Pharmacol Sci; 2022 Feb; 148(2):229-237. PubMed ID: 35063138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antiplatelet therapy: update in secondary stroke prevention].
    Uchiyama S
    Brain Nerve; 2013 Jul; 65(7):771-82. PubMed ID: 23832980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a systematic review and meta-analysis.
    Ding L; Peng B
    Eur J Neurol; 2018 Oct; 25(10):1276-1284. PubMed ID: 29855121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
    Hankey GJ
    Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis.
    McHutchison C; Blair GW; Appleton JP; Chappell FM; Doubal F; Bath PM; Wardlaw JM
    Stroke; 2020 Aug; 51(8):2374-2385. PubMed ID: 32646330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial.
    Pearce LA; McClure LA; Anderson DC; Jacova C; Sharma M; Hart RG; Benavente OR;
    Lancet Neurol; 2014 Dec; 13(12):1177-85. PubMed ID: 25453457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.